Skip to Main Content
Table 1—

DRAs in women with GDM

AuthornICA prevalence (%)IAA prevalence (%)GADA prevalence (%)I-A2A prevalence (%)
Steel et al. (17) 50 10    
Ginsberg-Fellner et al. (20)* 88 35    
Fallucca et al. (18) 39    
Freinkel et al. (1) 160 7.5    
Stowers et al. (19) 72 12.5    
Catalano et al. (21) 187 1.6    
Bell et al. (22) 181 2.8    
Stangerberg et al. (23) 55 1.8    
Mauricio et al. (24) 307 12.4    
Ziegler et al. (25) 55 11    
Damm et al. (26) 139 2.9§ 0§   
Tuomilehto et al. (50) 112   5.0  
Beischer et al. (51) 734   1.8  
Mauricio et al. (3) 203    
Petersen et al. (52) 139   2.2§  
Lapolla et al. (27) 68 2.9 1.5   
Dozio et al. (28) 145 10§ 3.0§ 0§ 0§ 
Fuchtenbusch et al. (29) 437 8.5  9.5 6.2 
Fallucca et al. (53) 83   3.6§  
Whittingham et al. (30) 98  
Panczel et al. (31) 68 14.7    
Kinalski et al. (32) 156 5.1  7.0 3.2 
Mitchell et al. (54) 100   6  
Bartha et al. (33) 102 0.98  10.8  
Kousta et al. (55) 321   4.0  
Weng et al. (56) 66   4.5§  
Balaji et al. (57) 86  41 GADA/IA-2†  
Lapolla et al. (34) 70 2.8  1.4 
Albareda et al. (35) 535 14  1.5 0.2 
Bo et al. (36) 123 6.5  4.1  
Järvelä et al. (37) 435 12.5 5.9 4.7 1.0§ 
AuthornICA prevalence (%)IAA prevalence (%)GADA prevalence (%)I-A2A prevalence (%)
Steel et al. (17) 50 10    
Ginsberg-Fellner et al. (20)* 88 35    
Fallucca et al. (18) 39    
Freinkel et al. (1) 160 7.5    
Stowers et al. (19) 72 12.5    
Catalano et al. (21) 187 1.6    
Bell et al. (22) 181 2.8    
Stangerberg et al. (23) 55 1.8    
Mauricio et al. (24) 307 12.4    
Ziegler et al. (25) 55 11    
Damm et al. (26) 139 2.9§ 0§   
Tuomilehto et al. (50) 112   5.0  
Beischer et al. (51) 734   1.8  
Mauricio et al. (3) 203    
Petersen et al. (52) 139   2.2§  
Lapolla et al. (27) 68 2.9 1.5   
Dozio et al. (28) 145 10§ 3.0§ 0§ 0§ 
Fuchtenbusch et al. (29) 437 8.5  9.5 6.2 
Fallucca et al. (53) 83   3.6§  
Whittingham et al. (30) 98  
Panczel et al. (31) 68 14.7    
Kinalski et al. (32) 156 5.1  7.0 3.2 
Mitchell et al. (54) 100   6  
Bartha et al. (33) 102 0.98  10.8  
Kousta et al. (55) 321   4.0  
Weng et al. (56) 66   4.5§  
Balaji et al. (57) 86  41 GADA/IA-2†  
Lapolla et al. (34) 70 2.8  1.4 
Albareda et al. (35) 535 14  1.5 0.2 
Bo et al. (36) 123 6.5  4.1  
Järvelä et al. (37) 435 12.5 5.9 4.7 1.0§ 

Adapted from Lauenborg et al. (84). For groups with several articles on the subject, the first article reporting the prevalence of each autoantibody is included.

*

The method was later shown to produce false-positive results.

P < 0.05 vs. the control population.

Measurements were performed at different times after delivery;

§

NS vs. the control population. ‖Women had both GDM and a positive family history of diabetes.

Close Modal

or Create an Account

Close Modal
Close Modal